The invention relates to the use of compounds of formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, in the preparation of a medicament for inhibiting the activity of DNA-PK, wherein R
1
and R
2
are independently hydrogen, an optionally substituted C
1-7
alkyl group, C
3-20
heterocyclyl group, or C
5-20
aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; X and Y are selected from CR
4
and O, O and CR′
4
and NR″
4
and N, where the unsaturation is in the appropriate place in the ring, and where one of R
3
and R
4
or R′
4
is an optionally substituted C
3-20
heteroaryl or C
5-20
aryl group, and the other of R
3
and R
4
or R′
4
is H, or R
3
and R
4
or R″
4
together are —A—B—, which collectively represent a fused optionally substituted aromatic ring. The compounds also selectively inhibit the activity of DNA-PK compared to PI 3-kinase and/or ATM.
1
本发明涉及使用式(I)化合物及其异构体、盐、溶剂合物、
化学保护形式及其前药,在制备抑制DNA-PK活性的药物方面使用。其中,R1和R2分别为
氢、可选取代的C1-7烷基、C3-20杂环基或C5-20芳基,或者与它们连接的
氮原子一起形成含有4到8个环原子的可选取代杂环环;X和Y从CR4和O、O和CR'4以及NR"4和N中选择,其中不饱和度在环中适当位置,且R3和R4或R'4中的一个为可选取代的C3-20杂芳基或C5-20芳基,而另一个为
氢,或者R3和R4或R"4一起为-A-B-,它们共同表示一个融合的可选取代芳香环。这些化合物与
PI 3-激酶和/或A
TM相比,也具有选择性抑制DNA-PK活性的作用。